B

Biofabri at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

Biofabri takes part in 2 sessions at World Vaccine Congress Europe 2026 in Amsterdam. Its program centres on tuberculosis vaccines. The most concrete session sets out a global manufacturing and access strategy for the MTBVAC TB vaccine.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
B
Biofabri
Biotech
Spanish vaccine company in the Zendal group developing and manufacturing the MTBVAC tuberculosis vaccine.
Talk
Wed Oct 21
12:45
Global Manufacturing and Access Strategy for a TB Vaccine: MTBVAC
AMR & Bacterial Vaccines
Panel
Wed Oct 21
14:30
Panel: Can TB vaccines deliver on the promise?
What tuberculosis vaccine trials can learn from COVID-19, flu and respiratory syncytial virus, and how to make tuberculosis a funding priority.
with London School of Hygiene & Tropical Medicine, Novo Nordisk Foundation Initiative for Vaccines and Immunity, European Vaccine Initiative +2 more

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Biofabri

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction